The odds ratio for the association between the PRSER+ and ER-positive breast cancer risk for BRCA1 carriers (OR = 1.79, 95% CI = 1.30 to 2.48; Table 1) was somewhat higher compared with the odds ratio for overall breast cancer. This evidence concerns the gene BRCA1 and breast cancer.